INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | 0.0% | 4,002 | -7.1% | 0.00% | 0.0% |
| Q2 2023 | $2 | -33.3% | 4,306 | +6.2% | 0.00% | -33.3% |
| Q1 2023 | $3 | -81.2% | 4,053 | -58.1% | 0.00% | -57.1% |
| Q4 2022 | $16 | -99.8% | 9,680 | +92.7% | 0.01% | -12.5% |
| Q3 2022 | $9,000 | 0.0% | 5,024 | -0.1% | 0.01% | +14.3% |
| Q2 2022 | $9,000 | -60.9% | 5,028 | -23.0% | 0.01% | -53.3% |
| Q1 2022 | $23,000 | -45.2% | 6,528 | -21.8% | 0.02% | -74.6% |
| Q4 2021 | $42,000 | – | 8,347 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |